368 related articles for article (PubMed ID: 27898687)
21. Respiratory Syncytial Virus Associated Hospitalizations in Infants of 33 to 42 Weeks' Gestation: Does Gestational Age Matter?
Resch B; Wörner C; Özdemir S; Hubner M; Puchas C; Urlesberger B
Klin Padiatr; 2019 Jul; 231(4):206-211. PubMed ID: 30887492
[TBL] [Abstract][Full Text] [Related]
22. The 2014-2015 National Impact of the 2014 American Academy of Pediatrics Guidance for Respiratory Syncytial Virus Immunoprophylaxis on Preterm Infants Born in the United States.
Kong AM; Krilov LR; Fergie J; Goldstein M; Diakun D; Wade SW; Pavilack M; McLaurin KK
Am J Perinatol; 2018 Jan; 35(2):192-200. PubMed ID: 28881376
[TBL] [Abstract][Full Text] [Related]
23. Predictors of RSV LRTI Hospitalization in Infants Born at 33 to 35 Weeks Gestational Age: A Large Multinational Study (PONI).
Straňák Z; Saliba E; Kosma P; Posfay-Barbe K; Yunis K; Farstad T; Unnebrink K; van Wyk J; Wegzyn C; Notario G; Kalus S; Campbell FJ
PLoS One; 2016; 11(6):e0157446. PubMed ID: 27310438
[TBL] [Abstract][Full Text] [Related]
24. Incidence of respiratory syncytial virus bronchiolitis in hospitalized infants born at 33-36 weeks of gestational age compared with those born at term: a retrospective cohort study.
Greenberg D; Dagan R; Shany E; Ben-Shimol S; Givon-Lavi N
Clin Microbiol Infect; 2020 Feb; 26(2):256.e1-256.e5. PubMed ID: 31181285
[TBL] [Abstract][Full Text] [Related]
25. Total healthcare costs in the US for preterm infants with respiratory syncytial virus lower respiratory infection in the first year of life requiring medical attention.
Stewart DL; Romero JR; Buysman EK; Fernandes AW; Mahadevia PJ
Curr Med Res Opin; 2009 Nov; 25(11):2795-804. PubMed ID: 19788406
[TBL] [Abstract][Full Text] [Related]
26. Update on respiratory syncytial virus hospitalizations among U.S. preterm and term infants before and after the 2014 American Academy of Pediatrics policy on immunoprophylaxis: 2011-2017.
Fergie J; Goldstein M; Krilov LR; Wade SW; Kong AM; Brannman L
Hum Vaccin Immunother; 2021 May; 17(5):1536-1545. PubMed ID: 33090914
[TBL] [Abstract][Full Text] [Related]
27. Association of Age With Risk of Hospitalization for Respiratory Syncytial Virus in Preterm Infants With Chronic Lung Disease.
Winterstein AG; Choi Y; Meissner HC
JAMA Pediatr; 2018 Feb; 172(2):154-160. PubMed ID: 29204660
[TBL] [Abstract][Full Text] [Related]
28. Increasing Rates of RSV Hospitalization among Preterm Infants: A Decade of Data.
Kong AM; Winer IH; Zimmerman NM; Diakun D; Bloomfield A; Gonzales T; Fergie J; Goldstein M; Krilov LR
Am J Perinatol; 2023 Oct; 40(14):1529-1536. PubMed ID: 34704241
[TBL] [Abstract][Full Text] [Related]
29. Outpatient RSV lower respiratory infections among high-risk infants and other pediatric populations.
Paramore LC; Mahadevia PJ; Piedra PA
Pediatr Pulmonol; 2010 Jun; 45(6):578-84. PubMed ID: 20503283
[TBL] [Abstract][Full Text] [Related]
30. Respiratory Syncytial Virus Related Readmission in Preterm Infants Less than 34 weeks' Gestation Following Discharge from a Neonatal Intensive Care Unit in Korea.
Lee JH; Kim CS; Chang YS; Choi JH;
J Korean Med Sci; 2015 Oct; 30 Suppl 1(Suppl 1):S104-10. PubMed ID: 26566351
[TBL] [Abstract][Full Text] [Related]
31. Efficacy of motavizumab for the prevention of respiratory syncytial virus disease in healthy Native American infants: a phase 3 randomised double-blind placebo-controlled trial.
O'Brien KL; Chandran A; Weatherholtz R; Jafri HS; Griffin MP; Bellamy T; Millar EV; Jensen KM; Harris BS; Reid R; Moulton LH; Losonsky GA; Karron RA; Santosham M;
Lancet Infect Dis; 2015 Dec; 15(12):1398-408. PubMed ID: 26511956
[TBL] [Abstract][Full Text] [Related]
32. Rehospitalisations for respiratory disease and respiratory syncytial virus infection in preterm infants of 29-36 weeks gestational age.
Resch B; Pasnocht A; Gusenleitner W; Müller W
J Infect; 2005 Jun; 50(5):397-403. PubMed ID: 15907547
[TBL] [Abstract][Full Text] [Related]
33. Respiratory syncytial virus (RSV) infection in preterm infants and the protective effects of RSV immune globulin (RSVIG). Respiratory Syncytial Virus Immune Globulin Study Group.
Groothuis JR; Simoes EA; Hemming VG
Pediatrics; 1995 Apr; 95(4):463-7. PubMed ID: 7700741
[TBL] [Abstract][Full Text] [Related]
34. Risk of RSV-related hospitalization is associated with gestational age in preterm (born at 29-34 wGA) infants without outpatient palivizumab administration.
Packnett ER; Winer IH; Oladapo A; Wojdyla M
Hum Vaccin Immunother; 2023 Aug; 19(2):2252289. PubMed ID: 37828711
[TBL] [Abstract][Full Text] [Related]
35. SENTINEL1: Two-Season Study of Respiratory Syncytial Virus Hospitalizations among U.S. Infants Born at 29 to 35 Weeks' Gestational Age Not Receiving Immunoprophylaxis.
Anderson EJ; DeVincenzo JP; Simões EAF; Krilov LR; Forbes ML; Pannaraj PS; Espinosa CM; Welliver RC; Wolkoff LI; Yogev R; Checchia PA; Domachowske JB; Halasa N; McBride SJ; Kumar VR; McLaurin KK; Rizzo CP; Ambrose CS
Am J Perinatol; 2020 Mar; 37(4):421-429. PubMed ID: 30991438
[TBL] [Abstract][Full Text] [Related]
36. Respiratory Syncytial Virus Disease: Immunoprophylaxis Policy Review and Public Health Concerns in Preterm and Young Infants.
Staebler S; Blake S
Policy Polit Nurs Pract; 2021 Feb; 22(1):41-50. PubMed ID: 33050785
[TBL] [Abstract][Full Text] [Related]
37. Trends in chronologic age and infant respiratory syncytial virus hospitalization: an 8-year cohort study.
Fryzek JP; Martone WJ; Groothuis JR
Adv Ther; 2011 Mar; 28(3):195-201. PubMed ID: 21327753
[TBL] [Abstract][Full Text] [Related]
38. Respiratory syncytial virus infection in infants in rural Nepal.
Chu HY; Katz J; Tielsch J; Khatry SK; Shrestha L; LeClerq SC; Magaret A; Kuypers J; Steinhoff M; Englund JA
J Infect; 2016 Aug; 73(2):145-54. PubMed ID: 27241525
[TBL] [Abstract][Full Text] [Related]
39. Increased risk for respiratory syncytial virus-associated, community-acquired alveolar pneumonia in infants born at 31-36 weeks of gestation.
Greenberg D; Dagan R; Shany E; Bar-Ziv J; Givon-Lavi N
Pediatr Infect Dis J; 2014 Apr; 33(4):381-6. PubMed ID: 24145171
[TBL] [Abstract][Full Text] [Related]
40. Rehospitalization because of respiratory syncytial virus infection in premature infants younger than 33 weeks of gestation: a prospective study. IRIS Study Group.
Carbonell-Estrany X; Quero J; Bustos G; Cotero A; Doménech E; Figueras-Aloy J; Fraga JM; García LG; García-Alix A; Del Río MG; Krauel X; Sastre JB; Narbona E; Roqués V; Hernández SS; Zapatero M
Pediatr Infect Dis J; 2000 Jul; 19(7):592-7. PubMed ID: 10917214
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
